Keryx Biopharmaceuticals, Inc.

(NASDAQ:KERX)

0.15

+0.01 (7.14%)

Dec 04 - Close

Open
0.15
High
0.16
Low
0.14
Vol.
190.16K
Mkt Cap
6.39M
52Wk High
9.70
52Wk Low
0.10
Avg. Vol.
452.30K
P/E (Trailing)
-0.07
Beta
0.36
Short %
3.50%
Div. Yield
—

After-Hours 0.16 +0.01 (6.67%) Thu, 4 Dec 2008 7:40 PM

Company Profile

Keryx Biopharmaceuticals, Inc.

750 Lexington Avenue

New York, NY 10022

United States - Map

Phone: (212) 531-5965

Fax: (212) 531-5961

Website: www.keryx.com

State of incorporation: Delaware

CEO: Michael S. Weiss, J.D.

Employees: 50

Sector: Healthcare

Industry Group: Drugs

Industry: Drug Manufacturers - Major

Is a biopharmaceutical company

A biopharmaceutical company focused on the acquisition and development of novel pharmaceutical products for the treatment of life-threatening diseases, including diabetes and cancer.

Recent news for KERX

Recent opinions on KERX

No recent Opinions for KERX

Top members owning KERX

  • Top 42%

    avereles

    avereles

    -29.32%3m:

    -25.33%YTD:

Members owning KERX also own

TY (100.00%), PLX (100.00%), ESLT (100.00%), GENZ (100.00%), GE (100.00%)

Member sentiment: Neutral